The ERK and p38MAPK Pathways as Targets for Anti-Inflammatory Therapy

E-ISSN： 1875-614x|6|1|85-97

ISSN： 1871-5230

Source： Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol.6, Iss.1, 2007-01, pp. : 85-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production

By Boire Gilles

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 5, 2013-01 ,pp. : 353-361

NRC Research Press

Access to resources Recommend Favorite

Hyperglycemia Regulates TXNIP/TRX/ROS Axis via p38 MAPK and ERK Pathways in Pancreatic Cancer

Current Cancer Drug Targets, Vol. 14, Iss. 4, 2014-05 ,pp. : 348-356

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases as Targets for Anti-Inflammatory Therapy

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and Receptors as Targets in Anti-Inflammatory Therapy

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 1, Iss. 2, 2002-09 ,pp. : 123-130

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy

By Getting S.J.

Trends in Pharmacological Sciences, Vol. 23, Iss. 10, 2002-10 ,pp. : 447-449

Elsevier

Access to resources Recommend Favorite